Background: Antenatal magnesium sulphate, widely used in obstetrics to improve maternal and infant outcomes, may be associated with adverse effects for the mother sufficient for treatment ...
Included neonates simultaneously met the following two conditions: (1) occurrence of NA within 28 days of life; (2) abnormal 12-lead electrocardiography (ECG) and/or abnormal 24-h Holter ECG. If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback